Privo Technologies, Inc. is focused on changing the oncology treatment paradigm with its Programmed Release Vehicle (PRV) technology....
3 Things to Know Before Getting the Covid-19 Vaccine
A fast vaccination will push the world entering the stage of herd immunity, namely enough population will have gained immune protection against the COVID-19 virus and the infection will no longer be able to spread easily. Unlike healthy people, cancer patients need to know much more than just the assigned…...
Lymphoma is Largely Gone After Covid-19 Infection: Demonstrating the Power of the Immune System
A 61‐year‐old man with stage III Hodgkin lymphoma was hospitalized for the infection of Covid-19 in the UK. He was hospitalized for 11 days and did not receive any cancer treatment. Four months later, the PET-CT scan result showed that his lymphoma was largely gone! Left: Before, Right: After Everyone…...
Cancer and Diet: Does it Really Matter?
Living a healthy life can be challenging when there are seemingly endless fad diets, do’s and don’ts, celebrity tips, and kitchen hacks. It can all seem a little overwhelming. The truth is that being healthy is not as difficult or restrictive as people are led to believe. These excessively restrictive…...
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Privo Technologies to Receive $900,000 of Investment Funding Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition, a first of its kind program for female entrepreneurs starting oncology companies. Privo Technologies has developed a nano-engineered platform…...
3 Things to Know Before Getting the Covid-19 Vaccine
Unlike healthy people, cancer patients need to know much more than just the assigned priority tier before getting the vaccine shots, since many of them may have weakened immune systems caused either by cancer or the treatment received. The following 3 tips could help cancer patients to consult with their…...
High Impact Collaboration — Developing Next-Generation Inhibitors to a Key Cancer Pathway
THE CHALLENGE —Tackling the Pre-Clinical Experiments to Overcome Drug Resistance Many patients with melanoma, papillary thyroid tumors, serous ovarian tumors, and colorectal tumors, for example, have DNA mutations that hyperactivate the major cell growth and survival pathway Ras/Raf/MEK/ERK, causing abnormal growth and cancer. Unfortunately, patients may have an intrinsic resistance…...
